Associated Papers
Pharmacogenomics in cardiac therapy: Personalizing treatment for heart health.
Naderi N et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 2025
Genetic Factors Associated With Myocardial Infarction in Saudi Arabia.
Saeed A et al.
Journal of the Saudi Heart Association, 2025
Predicted deleterious variants in ABCA1, LPL, LPA and KIF6 are associated with statin response and adverse events in patients with familial hypercholesterolemia and disturb protein structure and stability.
Dagli-Hernandez C et al.
Pharmacogenetics and Genomics, 2024
Kif6 regulates cilia motility and polarity in brain ependymal cells.
Takagishi M et al.
Biorxiv : the Preprint Server for Biology, 2023
KIF6 Trp719Arg Genetic Variant Increases Risk for Thoracic Aortic Dissection.
Velasco JJ et al.
Genes, 2023
Construction of copy number variation landscape and characterization of associated genes in a Bangladeshi cohort of neurodevelopmental disorders.
Akter H et al.
Frontiers in Genetics, 2023
Sensitization of Patient-Derived Colorectal Cancer Organoids to Photon and Proton Radiation by Targeting DNA Damage Response Mechanisms.
Pape K et al.
Cancers, 2022
Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry.
Bateman NW et al.
Iscience, 2022
Coronary Heart Disease in Type 2 Diabetes Mellitus: Genetic Factors and Their Mechanisms, Gene-Gene, and Gene-Environment Interactions in the Asian Populations.
Zarkasi KA et al.
International Journal of Environmental Research and Public Health, 2022
Impact of 719Trp>Arg Polymorphism of KIF 6 Gene on Contrast Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention.
Barbieri L et al.
Global Heart, 2022
Association between rs20456 and rs6930913 of Kinesin-Like Family 6 and Hypertension in a Chinese Cohort.
Chen YL et al.
International Journal of Hypertension, 2021
Predictive impact of rare genomic copy number variations in siblings of individuals with autism spectrum disorders.
D'Abate L et al.
Nature Communications, 2019
Pharmacogenetics of statins treatment: Efficacy and safety.
Guan ZW et al.
Journal of Clinical Pharmacy and Therapeutics, 2019
Introducing the first whole genomes of nationals from the United Arab Emirates.
AlSafar HS et al.
Scientific Reports, 2019
A meta-analysis of Italian and Estonian individuals shows an effect of common variants in HMGCR on blood apoB levels.
Rosticci M et al.
Biomarkers in Medicine, 2019
SNP rs10800708 within the KIF14 miRNA binding site is linked with breast cancer.
Shasttiri A et al.
British Journal of Biomedical Science, 2019
Genome-wide association study and meta-analysis identify loci associated with ventricular and supraventricular ectopy.
Napier MD et al.
Scientific Reports, 2018
OTUD7A Regulates Neurodevelopmental Phenotypes in the 15q13.3 Microdeletion Syndrome.
Uddin M et al.
American Journal of Human Genetics, 2018
De novo and rare inherited copy-number variations in the hemiplegic form of cerebral palsy.
Zarrei M et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2018
Association between KIF6 rs20455 polymorphism and the risk of coronary heart disease (CHD): a pooled analysis of 50 individual studies including 40,059 cases and 64,032 controls.
Li Y et al.
Lipids in Health and Disease, 2018
KIF6 gene as a pharmacogenetic marker for lipid-lowering effect in statin treatment.
Ruiz-Iruela C et al.
Plos One, 2018
Relationship between Lipid Phenotypes, Overweight, Lipid Lowering Drug Response and KIF6 and HMG-CoA Genotypes in a Subset of the Brisighella Heart Study Population.
Angelini S et al.
International Journal of Molecular Sciences, 2017
Impact of IQ on the diagnostic yield of chromosomal microarray in a community sample of adults with schizophrenia.
Lowther C et al.
Genome Medicine, 2017
Exome sequencing deciphers a germline MET mutation in familial epidermal growth factor receptor-mutant lung cancer.
Tode N et al.
Cancer Science, 2017
Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins.
Arrigoni E et al.
International Journal of Molecular Sciences, 2017
Effect of polymorphisms in interleukin-18 gene on the susceptibility to coronary artery disease in a Chinese population.
Ma JB et al.
Genetics and Molecular Research : Gmr, 2016
Indexing Effects of Copy Number Variation on Genes Involved in Developmental Delay.
Uddin M et al.
Scientific Reports, 2016
KIF6 719Arg Genetic Variant and Risk for Thoracic Aortic Dissection.
Iakoubova OA et al.
Aorta (stamford, Conn.), 2016
Impact of KIF6 Polymorphism rs20455 on Coronary Heart Disease Risk and Effectiveness of Statin Therapy in 100 Patients from Southern Iran.
Hamidizadeh L et al.
Archives of Iranian Medicine, 2015
Genotyping and meta-analysis of KIF6 Trp719Arg polymorphism in South Indian Coronary Artery Disease patients: A case-control study.
Vishnuprabu D et al.
Meta Gene, 2015
Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population.
Di Taranto MD et al.
Molecular and Cellular Probes, 2015
The Trp719Arg polymorphism of the KIF6 gene and coronary heart disease risk: systematic review and meta-analysis.
Ruiz-Ramos D et al.
Hereditas, 2015
Applying genome-wide gene-based expression quantitative trait locus mapping to study population ancestry and pharmacogenetics.
Yang HC et al.
Bmc Genomics, 2014
A genome-wide copy number association study of osteoporotic fractures points to the 6p25.1 locus.
Oei L et al.
Journal of Medical Genetics, 2014
The Association between KIF6 Single Nucleotide Polymorphism rs20455 and Serum Lipids in Filipino-American Women.
Ancheta IB et al.
Nursing Research and Practice, 2014
CHD2 haploinsufficiency is associated with developmental delay, intellectual disability, epilepsy and neurobehavioural problems.
Chénier S et al.
Journal of Neurodevelopmental Disorders, 2014
Novel KIF6 polymorphism increases susceptibility to type 2 diabetes mellitus and coronary heart disease in Han Chinese men.
Wu G et al.
Journal of Diabetes Research, 2014
Added value of pharmacogenetic testing in predicting statin response: results from the REGRESS trial.
van der Baan FH et al.
The Pharmacogenomics Journal, 2013
Pharmacogenetics and cardiovascular disease--implications for personalized medicine.
Johnson JA et al.
Pharmacological Reviews, 2013
Pharmacogenomics and cardiovascular disease.
Weeke P et al.
Current Cardiology Reports, 2013
Deletions in 16q24.2 are associated with autism spectrum disorder, intellectual disability and congenital renal malformation.
Handrigan GR et al.
Journal of Medical Genetics, 2013
No evidence for cardiac dysfunction in Kif6 mutant mice.
Hameed A et al.
Plos One, 2013
Association of KIF6 variant with lipid level and angiographic coronary artery disease events risk in the Han Chinese population.
Wu G et al.
Molecules (basel, Switzerland), 2012
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study.
Voight BF et al.
Lancet (london, England), 2012
SNP-based large-scale identification of allele-specific gene expression in human B cells.
Song MY et al.
Gene, 2012
Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias.
Clarke R et al.
Plos Medicine, 2012
Current State and Future Prospects of Direct-to-Consumer Pharmacogenetics.
Chua EW et al.
Frontiers in Pharmacology, 2012
Meta-analyses of KIF6 Trp719Arg in coronary heart disease and statin therapeutic effect.
Peng P et al.
Plos One, 2012